Dodek Peter, Keenan Sean, Cook Deborah, Heyland Daren, Jacka Michael, Hand Lori, Muscedere John, Foster Debra, Mehta Nav, Hall Richard, Brun-Buisson Christian
University of British Columbia, Vancouver, British Columbia, Canada.
Ann Intern Med. 2004 Aug 17;141(4):305-13. doi: 10.7326/0003-4819-141-4-200408170-00011.
Ventilator-associated pneumonia (VAP) is an important patient safety issue in critically ill patients.
To develop an evidence-based guideline for the prevention of VAP.
MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews.
The authors systematically searched for relevant randomized, controlled trials and systematic reviews that involved mechanically ventilated adults and were published before 1 April 2003.
Physical, positional, and pharmacologic interventions that may influence the development of VAP were considered. Independently and in duplicate, the authors scored the validity of trials; the effect size and confidence intervals; the homogeneity of results; and safety, feasibility, and economic issues.
Recommended: The orotracheal route of intubation, changes of ventilator circuits only for each new patient and if the circuits are soiled, use of closed endotracheal suction systems that are changed for each new patient and as clinically indicated, heat and moisture exchangers in the absence of contraindications, weekly changes of heat and moisture exchangers, and semi-recumbent positioning in the absence of contraindications. Consider subglottic secretion drainage and kinetic beds. Not recommended: Sucralfate to prevent VAP in patients at high risk for gastrointestinal bleeding and topical antibiotics to prevent VAP. Because of insufficient or conflicting evidence, no recommendations were made about systematically searching for maxillary sinusitis, chest physiotherapy, the timing of tracheostomy, prone positioning, prophylactic intravenous antibiotics, or intravenous plus topical antibiotics.
No formal economic analysis was performed, and patient perspectives were not considered.
If effectively implemented, this guideline may decrease the morbidity, mortality, and costs of VAP in mechanically ventilated patients.
呼吸机相关性肺炎(VAP)是重症患者重要的患者安全问题。
制定预防VAP的循证指南。
MEDLINE、EMBASE和Cochrane系统评价数据库。
作者系统检索了2003年4月1日前发表的、涉及机械通气成人患者的相关随机对照试验和系统评价。
考虑了可能影响VAP发生的物理、体位和药物干预措施。作者独立且重复地对试验的有效性、效应量和置信区间、结果的同质性以及安全性、可行性和经济问题进行评分。
推荐:经口气管插管途径;仅为每位新患者更换呼吸机回路,以及回路被污染时更换;使用为每位新患者更换且根据临床指征更换的封闭式气管内吸痰系统;在无禁忌证时使用热湿交换器;每周更换热湿交换器;在无禁忌证时采用半卧位。考虑声门下分泌物引流和动力床。不推荐:在有高胃肠道出血风险的患者中使用硫糖铝预防VAP,以及使用局部抗生素预防VAP。由于证据不足或相互矛盾,未就系统筛查上颌窦炎、胸部物理治疗、气管切开时机、俯卧位、预防性静脉使用抗生素或静脉加局部使用抗生素提出建议。
未进行正式的经济分析,未考虑患者观点。
若有效实施,本指南可能降低机械通气患者VAP的发病率、死亡率和费用。